Search
Argenx's CEO on using FcRn to target IgG mediated autoimmune diseases
Tim Van Hauwermeiren describes the science behind argenx's success, the potential market potential, pipeline programs, and Europe.
Jan 9, 2024
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page